DC Investments Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46,333
Closed -$284K 86
2025
Q3
$284K Sell
46,333
-30,898
-40% -$195K 0.12% 88
2025
Q2
$500K Sell
77,231
-41,131
-35% -$222K 0.21% 71
2025
Q1
$629K Hold
118,362
0.32% 50
2024
Q4
$994K Hold
118,362
0.65% 40
2024
Q3
$934K Hold
118,362
0.65% 41
2024
Q2
$1.22M Hold
118,362
1.03% 26
2024
Q1
$1.48M Hold
118,362
1.2% 22
2023
Q4
$1.82M Buy
118,362
+76,562
+183% +$1.07M 1.82% 12
2023
Q3
$613K Sell
41,800
-49,751
-54% -$775K 0.77% 33
2023
Q2
$1.62M Hold
91,551
1.87% 12
2023
Q1
$1.63M Hold
91,551
1.94% 12
2022
Q4
$1.79M Buy
91,551
+41,800
+84% +$847K 2.27% 16
2022
Q3
$949K Buy
+49,751
New +$1.01M 2.17% 17

Other funds holding TBI

DC Investments Management's TBI Position: Q4 2025 in Review

DC Investments Management sold out of Trueblue (TBI) in Q4 2025, closing a stake of 46,333 shares — an estimated $284K sold.

DC Investments Management first reported a position in TBI in Q3 2022 and held it in 13 quarters. The position peaked at $1.82M in Q4 2023. 110 funds tracked by Wall St. Rank hold TBI as of Q4 2025.

  • DC Investments Management reported no remaining Trueblue position as of Q4 2025 after selling out during the quarter.
  • DC Investments Management sold 46,333 Trueblue shares in Q4 2025, an estimated $284K.
  • DC Investments Management first reported a position in Trueblue in Q3 2022 and held it in 13 quarters.
  • DC Investments Management's Trueblue position peaked at $1.82M in Q4 2023.
  • 110 funds tracked by Wall St. Rank held Trueblue as of Q4 2025.

Based on DC Investments Management's 13F filing for Q4 2025, filed 13 Feb 2026.